ETC
ACET icon

Exchange Traded Concepts’s Adicet Bio ACET Stock Holding History

Exchange Traded Concepts’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,978
Closed -$107K – 1257
2024
Q4 		$107K Hold
6,978
– – ﹤0.01% 1130
2024
Q3 		$161K Buy
6,978
+352
+5% +$7.88K ﹤0.01% 1037
2024
Q2 		$128K Sell
6,626
-2,061
-24% -$55.2K ﹤0.01% 924
2024
Q1 		$327K Buy
8,687
+3,563
+70% +$147K 0.01% 772
2023
Q4 		$155K Buy
5,124
+1,299
+34% +$28.3K ﹤0.01% 828
2023
Q3 		$83.8K Buy
3,825
+1,982
+108% +$70K ﹤0.01% 955
2023
Q2 		$71.7K Buy
+1,843
New +$163K ﹤0.01% 995

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Exchange Traded Concepts's ACET Position: Q1 2025 in Review

Exchange Traded Concepts sold out of Adicet Bio (ACET) in Q1 2025, closing a stake of 6,978 shares — an estimated $107K sold.

Exchange Traded Concepts first reported a position in ACET in Q2 2023 and held it in 7 quarters. The position peaked at $327K in Q1 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q1 2025.

  • Exchange Traded Concepts reported no remaining Adicet Bio position as of Q1 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 6,978 Adicet Bio shares in Q1 2025, an estimated $107K.
  • Exchange Traded Concepts first reported a position in Adicet Bio in Q2 2023 and held it in 7 quarters.
  • Exchange Traded Concepts's Adicet Bio position peaked at $327K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2025.

Based on Exchange Traded Concepts's 13F filing for Q1 2025, filed 17 Apr 2025.